← Back to Clinical Trials
Recruiting NCT06102304

NCT06102304 Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06102304
Status Recruiting
Phase
Sponsor Cairo University
Condition Cervical Radiculopathy
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-04-06
Primary Completion 2025-11-29

Eligibility & Interventions

Sex All sexes
Min Age 36 Years
Max Age 46 Years
Study Type INTERVENTIONAL
Interventions
Focused Extracorpeal Shock waveSham Extracorpeal shock wave

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-04-06 with a primary completion date of 2025-11-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

BACKGROUND: Upper limb nerve root dysfunction with increased active myofascial trigger point in upper trapezius is common problem in patients with cervical radiculopathy. The purpose of this study was to evaluate the effect of Extracorpeal shock wave on the myo-electric and nerve function responses in patients with cervical radiculopathy.

Eligibility Criteria

Inclusion Criteria: 1. All patients suffer from unilateral discogenic cervical radiculopathy of lower cervical spine(C5-C6 and/ or C6-C7) as confirmed with MRI. 2. All patients suffer from pain and tenderness on active trigger points of the upper trapezius . 3. Age ranging from 36 to 46 years old. 4. Duration of symptoms more than 3 months to avoid acute stage of inflammation. 5. Side to side amplitude differences of 50% or more in DSSEPs measurement (Naguszewski et al.,2001) Exclusion Criteria: 1. Posterior osteophytes 2. Spinal canal stenosis 3. Rheumatoid arthritis 4. Vestibular insufficiency 5. Osteoporosis 6. Any signs or symptoms of myelopathy 7. Any abnormalities of deep sensation 8. Associated pathologies of upper cervical region or the upper limb that may cause overlapping with clinical findings as referred pain from costotransverse joint, rotator cuff tendonitis, cervical rib syndrome and entrapment neuropathy.

Contact & Investigator

Central Contact

Engy BadrEldin S Moustafa, PhD

✉ engybm.saleh@cu.edu.eg

📞 00201099445112

Principal Investigator

Engy BadrEldin S Moustafa, PhD

PRINCIPAL INVESTIGATOR

Faculty of Physical Therapy, Cairo University, Egypt

Frequently Asked Questions

Who can join the NCT06102304 clinical trial?

This trial is open to participants of all sexes, aged 36 Years or older, up to 46 Years, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06102304 currently recruiting?

Yes, NCT06102304 is actively recruiting participants. Contact the research team at engybm.saleh@cu.edu.eg for enrollment information.

Where is the NCT06102304 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT06102304 clinical trial?

NCT06102304 is sponsored by Cairo University. The principal investigator is Engy BadrEldin S Moustafa, PhD at Faculty of Physical Therapy, Cairo University, Egypt. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology